Celastrol, one of the active components of Tripterygium wilfordii, can inhibit the bone metastasis of PCa cells by inhibiting the VEGF pathway of bone marrow-derived endothelial progenitor cells (BM-EPCs) (Kuchta et al., 2017). This evidence concerns the gene VEGFA and posterior cortical atrophy.